Surgery Partners (SGRY) to Release Quarterly Earnings on Monday

Surgery Partners (NASDAQ:SGRY) is projected to announce its earnings results before the market opens on Monday, February 24th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $828.01 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $25.31 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a fifty day moving average price of $22.62 and a 200 day moving average price of $26.65. The company has a market cap of $3.22 billion, a P/E ratio of -52.73, a PEG ratio of 19.32 and a beta of 2.60. Surgery Partners has a 12 month low of $19.50 and a 12 month high of $34.10.

Analysts Set New Price Targets

A number of equities analysts recently commented on SGRY shares. Bank of America started coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 target price for the company. Macquarie reiterated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research note on Tuesday, November 19th. JPMorgan Chase & Co. lowered their target price on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Finally, Royal Bank of Canada decreased their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Surgery Partners has an average rating of “Moderate Buy” and a consensus price target of $36.56.

Insider Transactions at Surgery Partners

In other news, insider Harrison R. Bane sold 56,315 shares of the stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the completion of the sale, the insider now owns 107,037 shares in the company, valued at approximately $2,744,428.68. This represents a 34.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David T. Doherty sold 13,641 shares of the stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.61, for a total transaction of $349,346.01. Following the sale, the chief financial officer now owns 108,862 shares of the company’s stock, valued at $2,787,955.82. This trade represents a 11.14 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 96,733 shares of company stock worth $2,480,106. Company insiders own 2.30% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.